Meningitis ACWY

Meningitis ACWY is a vaccine that protects against 4 types of meningococcal bacteria that can cause meningitis and septicemia – both of which can be fatal. While all adults can benefit from the vaccine, it is particularly important for those about to attend university for the first time and for international travel.

Meningococcal meningitis is a highly serious form of bacterial meningitis that can lead to septicaemia (blood poisoning). It is spread by droplets that come from a person who is infected with the bacteria.

While meningococcal meningitis is rare, it is very serious and can lead to life-changing disabilities, such as amputations, hearing loss and brain damage. It is potentially life-threatening and therefore vaccination is strongly advised.

Who should have the Meningitis ACWY vaccine?

MenACWY is encouraged in adolescents aged 15-19 years old and University students prior to starting University as outbreaks can be more common.

It is also recommended for those that are travelling to areas of the world where Meningitis ACWY strains are more prevalent. Many Sub-Saharan African countries are considered high-risk, with transmission being year-round, peaking in the dry season.

Muslims undergoing the Hajj or Umrah pilgrimage will require proof of vaccination. A valid vaccination certificate is a Visa requirement for visiting Saudi Arabia for this purpose.
It is also recommended for all those with a severely compromised immune system (such as those with no spleen).